Skip to content

Comparison of laparoscopic type II and type III radical hysterectomy in the treatment of early stage cervical cancer: a multiple center prospective randomized controlled clinical study

Comparison of laparoscopic type II and type III radical hysterectomy in the treatment of early stage cervical cancer: a multiple center prospective randomized controlled clinical study

Status
Recruiting
Phases
Phase 3
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014929
Enrollment
Unknown
Registered
2018-02-23
Start date
2018-04-01
Completion date
Unknown
Last updated
2018-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

A:????II?????????
B: laparoscopic type II radical hysterectomy

Sponsors

The First Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Histologically confirmed primary adenocarcinoma, squamous cell carcinoma or adenosquamous carcinoma of the uterine cervix; 2. Patients with FIGO stage IA2, IB1 or IIA1 disease; 3. Patients with adequate bone marrow, renal and hepatic function: WBC > 3,000 cells/mcl, Platelets>100,000/mcl, Creatinine 5 years previous with no current evidence of disease; 7. Females aged 18 years or older.

Exclusion criteria

Exclusion criteria: 1. Any histological type other than adenocarcinoma, squamous cell carcinoma or adenosquamous carcinoma of the uterine cervix; 2. Tumor size greater than 4 cm; 3. FIGO stage IB2, IIA2 and II-IV; 4. Patients with a history of pelvic or abdominal radiotherapy; 5. Patients who are pregnant; 6. Patients with contraindications to surgery; 7. Patients with evidence of metastatic disease by conventional imaging studies, enlarged pelvic or aortic lymph nodes > 2cm; or histologically positive lymph nodes; 8. Unfit for Surgery: serious concomitant systemic disorders incompatible with the study (at the discretion of the investigator); 9. Patients unable to withstand prolonged lithotomy and steep trendelenburg position; 10. Patient compliance and geographic proximity that do not allow adequate follow-up.

Design outcomes

Primary

MeasureTime frame
overall survival;

Secondary

MeasureTime frame
Postoperative quality of life;the function of Urination and defecation;Progression free survival;the function of pelvic floor;

Countries

China

Contacts

Public ContactShuzhong Yao

The First Affiliated Hospital of Sun Yat-sen University

yszlfy@163.com+86 13602834127

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026